BackgroundCheck.run
Search For

Steven M Nadler, 72Conshohocken, PA

Steven Nadler Phones & Addresses

Conshohocken, PA   

121 Roy Ln, Huntingdon Vy, PA 19006    215-9471570   

Huntingdon Valley, PA   

7901 Bustleton Ave STE 308, Philadelphia, PA 19152    215-3384436   

7901 Bustleton Ave, Philadelphia, PA 19152   

5600 Summerdale Ave, Philadelphia, PA 19019   

Floral Park, NY   

121 Roy Ln, Huntingdon Vy, PA 19006   

Languages

English

Mentions for Steven M Nadler

Career records & work history

Medicine Doctors

Steven Nadler Photo 1

Dr. Steven M Nadler, Philadelphia PA - DDS (Doctor of Dental Surgery)

Specialties:
Dentistry
Address:
7901 Bustleton Ave Suite 308, Philadelphia, PA 19152
215-3384433 (Phone) 215-3384436 (Fax)
Languages:
English

Steven C. Nadler

Specialties:
Gastroenterology
Work:
Middlesex Monmouth Gastroenterology
222 Schanck Rd STE 302, Freehold, NJ 07728
732-5771999 (phone) 732-8455356 (fax)
Middlesex Monmouth Gastroenterology
100 Commons Way STE 150, Holmdel, NJ 07733
732-8569518 (phone) 732-8455356 (fax)
Middlesex Monmouth Gastroenterology
2 Hospital Plz STE 340, Old Bridge, NJ 08857
732-6079300 (phone)
Education:
Medical School
UMDNJ New Jersey Medical School at Newark
Graduated: 1987
Procedures:
Esophageal Dilatation, Colonoscopy, Endoscopic Retrograde Cholangiopancreatography (ERCP), Hemorrhoid Procedures, Sigmoidoscopy, Upper Gastrointestinal Endoscopy
Conditions:
Acute Pancreatitis, Anal Fissure, Anal or Rectal Abscess, Benign Polyps of the Colon, Celiac Disease, Cholelethiasis or Cholecystitis, Chronic Pancreatitis, Cirrhosis, Constipation, Diverticulitis, Diverticulosis, Esophagitis, Gastritis and Duodenitis, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Hemorrhoids, Infectious Liver Disease, Inflammatory Bowel Disease (IBD), Intestinal Obstruction, Intussusception, Irritable Bowel Syndrome (IBS), Ischemic Bowel Disease, Liver Cancer, Malignant Neoplasm of Esophagus, Pancreatic Cancer, Peptic Ulcer Disease
Languages:
English
Description:
Dr. Nadler graduated from the UMDNJ New Jersey Medical School at Newark in 1987. He works in Freehold, NJ and 2 other locations and specializes in Gastroenterology. Dr. Nadler is affiliated with Bayshore Community Hospital, Centrastate Medical Center, Raritan Bay Medical Center and Raritan Bay Medical Center Old Bridge Division.

Steven P. Nadler

Description:
Dr. Nadler graduated from the University of Miami, Miller School of Medicine in 1972. He works in Brooksville, FL and 1 other location and specializes in Orthopaedic Surgery. Dr. Nadler is affiliated with Morton Plant North Bay Hospital, Oak Hill Hospital and Regional Medical Center Bayonet Point.
Steven Nadler Photo 2

Steven M Nadler, Philadelphia PA

Specialties:
Dentist
Address:
7901 Bustleton Ave, Philadelphia, PA 19152
Steven Nadler Photo 3

Steven Nadler, Bay Shore NY

Specialties:
Dentist
Address:
1701 Sunrise Hwy, Bay Shore, NY 11706
49 Forest Rd, Monroe, NY 10950

License Records

Steven Mark Nadler

Address:
Philadelphia, PA 19152
Licenses:
License #: DS020697L - Active
Category: Dentistry
Type: Dentist

Steven M Nadler

Address:
121 Roy Ln, Huntingdon Valley, PA
Licenses:
License #: 9089 - Active
Category: Health Care
Issued Date: Feb 22, 1982
Effective Date: Jan 1, 1901
Expiration Date: Feb 28, 2018
Type: Dental

Publications & IP owners

Wikipedia

Steven Nadler Photo 27

Steven Nadler

Jun 14, 2009 ... Steven Nadler is the William H. Hay II Professor of Philosophy, and Max and Frieda Weinstein-Bascom Professor of Jewish Studies at the ...

Us Patents

Intracellular Targeted Delivery Of Compounds By 70 Kd Heat Shock Protein

US Patent:
6730302, May 4, 2004
Filed:
Nov 16, 1999
Appl. No.:
09/440967
Inventors:
Sheri M. Fujihara - Lawrenceville NJ
Steven G. Nadler - Princeton NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 39385
US Classification:
4241921, 4241931, 42419511, 512 2, 512 12
Abstract:
The present invention provides a carrier for the delivery of molecules with biological function into both cellular and nuclear compartments. The carrier disclosed is heat shock protein 70 (âHsp70â), or a fragment of Hsp70 as described herein, as a vehicle for directed, noninvasive delivery of molecules, such as proteins, peptides, or DNA, that may modulate cellular activity. The present invention also encompasses the use of Hsp70, or a fragment thereof, to modulate cellular activity, preferably to modulate nuclear activity in a cell or cells.

Methods Of Treating Inflammatory And Immune Diseases Using Inhibitors Of Iκb Kinase (Ikk)

US Patent:
6869956, Mar 22, 2005
Filed:
Feb 1, 2002
Appl. No.:
10/062847
Inventors:
James R. Burke - Holland PA, US
Robert M. Townsend - Boothwyn PA, US
Yuping Qiu - Windsor CT, US
Fred Christopher Zusi - Hamden CT, US
Steven G. Nadler - Boothwyn PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61P001/00
A61P011/06
A61P019/02
A61P037/06
C07D487/04
US Classification:
514250
Abstract:
The present invention describes methods of preventing and treating inflammatory and immune-related diseases or disorders using inhibitors of IκB kinase (IKK). Also described are IKK inhibitors effective for the prevention and treatment of inflammatory and immune-related diseases or disorders, as demonstrated in vivo. Further embodiments of the present invention relate to a specific IKK inhibitors, 4(2′-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline and compounds of formula (I), salts thereof, and pharmaceutical compositions.

Polynucleotides And Polypeptides Associated With The Development Of Rheumatoid Arthritis

US Patent:
7244573, Jul 17, 2007
Filed:
Dec 3, 2002
Appl. No.:
10/308279
Inventors:
Julie Carman - Lawrenceville NJ, US
Steven G. Nadler - Princeton NJ, US
Michael Bowen - Rockville MD, US
Michael G. Neubauer - Skillman NJ, US
Pin Lu - Princeton Jct. NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
G01N 33/53
G01N 33/564
C07H 21/04
US Classification:
435 71, 435 724, 536 235
Abstract:
The present invention is directed to polynucleotides encoding polypeptides associated with the development of rheumatoid arthritis and homologs thereof. The invention further relates to diagnostic and therapeutic methods for utilizing these polynucleotides and polypeptides in the diagnosis, treatment, and/or prevention of rheumatoid arthritis and related disease states. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, and compounds identified thereby.

Polynucleotides And Polypeptides Associated With The Development Of Rheumatoid Arthritis

US Patent:
7670785, Mar 2, 2010
Filed:
Jun 7, 2007
Appl. No.:
11/811442
Inventors:
Julie Carman - Lawrenceville NJ, US
Steven G. Nadler - Princeton NJ, US
Michael A. Bowen - Rockville MD, US
Michael G. Neubauer - Skillman NJ, US
Pin Lu - New York NY, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
G01N 33/53
G01N 33/52
G01N 33/554
C07H 21/04
US Classification:
435 71, 435 721, 435 724, 435 78, 536 235
Abstract:
The present invention is directed to polynucleotides encoding polypeptides associated with the development of rheumatoid arthritis and homologs thereof. The invention further relates to diagnostic and therapeutic methods for utilizing these polynucleotides and polypeptides in the diagnosis, treatment, and/or prevention of rheumatoid arthritis and related disease states. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, and compounds identified thereby.

Compositions Monovalent For Cd28 Binding And Methods Of Use

US Patent:
8168759, May 1, 2012
Filed:
Jul 17, 2009
Appl. No.:
12/505166
Inventors:
Murray McKinnon - Washington Crossing PA, US
Steven G. Nadler - Princeton NJ, US
Suzanne J. Suchard - Wilmington DE, US
Brendan Classon - Princeton NJ, US
Steve Holmes - Cambridge, GB
Olga Ignatovich - Cambridge, GB
Christopher Plummer - Cambridge, GB
Steve Grant - Cambridge, GB
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
Domantis Limited - Brentford, Middlesex
International Classification:
C07K 16/00
A61K 39/395
US Classification:
5303873, 4241351
Abstract:
Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual.

Compositions Monovalent For Cd28 Binding And Methods Of Use

US Patent:
8454959, Jun 4, 2013
Filed:
Mar 9, 2012
Appl. No.:
13/416033
Inventors:
Murray McKinnon - Washington Crossing PA, US
Steven G. Nadler - Princeton NJ, US
Suzanne J. Suchard - Wilmington DE, US
Brendan Classon - Princeton NJ, US
Steve Holmes - Cambridge, GB
Olga Ignatovich - Cambridge, GB
Christopher Plummer - Cambridge, GB
Steve Grant - Cambridge, GB
Assignee:
Bristol-Meyers Squibb Company - Princeton NJ
Domantis Limited - Brentford, Middlesex
International Classification:
A61K 39/395
US Classification:
4241301
Abstract:
Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual.

Polynucleotides And Polypeptides Associated With The Development Of Osteoarthritis

US Patent:
2003017, Sep 11, 2003
Filed:
Dec 3, 2002
Appl. No.:
10/308448
Inventors:
Julie Carman - Lawrenceville NJ, US
Steven Nadler - Princeton NJ, US
Michael Bowen - Rockville MD, US
Michael Neubauer - Skillman NJ, US
Pin Lu - Cherry Hill NJ, US
International Classification:
G01N033/53
G01N033/567
US Classification:
435/007200
Abstract:
The present invention is directed to polynucleotides encoding polypeptides associated with the development of osteoarthritis and homologs thereof. The invention further relates to diagnostic and therapeutic methods for utilizing these polynucleotides and polypeptides in the diagnosis, treatment, and/or prevention of osteoarthritis and related disease states. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention, and compounds identified thereby.

Polynucleotides And Polypeptides Associated With The Nf-Kb Pathway

US Patent:
2003022, Dec 4, 2003
Filed:
Apr 19, 2002
Appl. No.:
10/126103
Inventors:
Julie Carman - Lawrencevillle NJ, US
Steven Nadler - Princeton NJ, US
John Feder - Belle Mead NJ, US
International Classification:
C12P021/02
C07H021/04
C07K014/52
C12N005/06
US Classification:
435/069500, 435/320100, 435/325000, 530/351000, 536/023500
Abstract:
The present invention provides polynucleotides encoding NF-kB-associated polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these NF-kB-associated polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Isbn (Books And Publications)

Malebranche And Ideas

Author:
Steven Nadler
ISBN #:
0195077245

Oxford Studies In Early Modern Philosophy

Author:
Steven Nadler
ISBN #:
0199203938

Oxford Studies In Early Modern Philosophy

Author:
Steven Nadler
ISBN #:
0199203946

Oxford Studies In Early Modern Philosophy

Author:
Steven Nadler
ISBN #:
0199267901

Oxford Studies In Early Modern Philosophy

Author:
Steven Nadler
ISBN #:
0199279756

Oxford Studies In Early Modern Philosophy

Author:
Steven Nadler
ISBN #:
0199279764

Causation In Early Modern Philosophy: Cartesianism, Occasionalism, And Preestablished Harmony

Author:
Steven Nadler
ISBN #:
0271008636

Spinoza: A Life

Author:
Steven Nadler
ISBN #:
0521002931

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.